Most of last month's biggest large-cap laggards lost ground for the exact same reasons their peers did. That's telling.
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of the #RAREis Representation program, which expands Horizon’s #RAREis program to support advancing global equity in the rare disease...
CEO Carl Hess leads Nasdaq bell ringing ceremony to mark Willis Towers Watson’s new future as WTW...
ARLINGTON, Va. and LONDON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- WTW (Willis Towers Watson, NASDAQ: WTW), a leading global advisory, broking and solutions...
One in three employers bumped up original salary increase projections...
Renewable energy growth creating increased demand for transition plans outlined in WTW’s annual Renewable Energy Market Review...
Special Contingency Risks (SCR) and Terror / Political Violence unit combine to create one Global Crisis Management segment...
ARLINGTON, Va., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, today...
Recording their first positive annual performance in five years, deal makers expect M&A activity to continue to increase this year and ESG issues to...
Funded status jumped to 96%, up 8 percentage points during 2021, Willis Towers Watson analysis finds...